Lakefront Biotherapeutics(DE:GXEA)
€30.80+1.00 (+3.36%)
DE:GXEA
Lakefront Biotherapeutics earnings date
€30.80
At close:+1.00 (+3.36%)
Lakefront Biotherapeutics (GXEA) Q4 2022 Earnings Report
0 Followers
DE:GXEA Q4 2022 EPS Results
- Actual EPS
- -EUR 3.00
- Consensus EPS
- -EUR 0.59
- Beat/Miss
- Missed by -EUR 2.42
- One Year Ago EPS
- EUR 0.25
DE:GXEA Q4 2022 Revenue Results
- Actual Revenue
- EUR 87.65M
- Expected Revenue
- EUR 118.31M
- Beat/Miss
- Missed by -EUR 30.66M
- YoY Revenue Growth
- -49.20%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/23/2023
- Time
- After Close
- Conference Call
- Thursday, February 23, 2023
DE:GXEA Upcoming Earnings
Lakefront Biotherapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
DE:GXEA Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GXEA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | -0.68- | 12.56 | ― | ― |
| Nov 11, 2026 | 2026 (Q3) | -0.33-0.04 | -3.2 | 98.76% (+3.16) | |
| Aug 10, 2026 | 2026 (Q2) | -0.740.03 | -1.67 | 101.83% (+1.71) | |
| May 06, 2026 | 2026 (Q1) | -0.850.22 | -2.42 | 109.24% (+2.64) | |
| Feb 23, 2026 | 2025 (Q4) | ―12.56 | 0.27 | 4502.65% (+12.29) | |
| Nov 05, 2025 | 2025 (Q3) | -0.43-3.20 | -0.73 | -341.22% (-2.48) | |
| Jul 23, 2025 | 2025 (Q2) | -0.21-1.67 | 0.07 | -2475.64% (-1.75) | |
| Apr 23, 2025 | 2025 (Q1) | -0.13-2.42 | 0.35 | -788.92% (-2.77) | |
| Feb 12, 2025 | 2024 (Q4) | -0.500.27 | 2.34 | -88.32% (-2.06) | |
| Oct 30, 2024 | 2024 (Q3) | -0.15-0.73 | 0.38 | -291.65% (-1.10) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
